| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Acalabrutinib |
|---|
| Description | MW: 465.52. Purity ≥98% by HPLC. Acalabrutinib (ACP-196) is an orally available; selective irreversible inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It is a second generation BTK inhibitor with improved pharmacological properties with better plasma exposure; oral absorption and shorter half-life. It prevents the activation of B-cell antigen receptor (BCR) signaling pathway; thus preventing B-cell activation and BTK mediated activation of downstream survi |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [(S)-4- (8-amino-3- (1- (but-2-ynoyl) pyrrolidin-2-yl) imidazo[1; 5-a]pyrazin-1-yl)-N- (pyridin-2-yl) benzamide; ACP-196] |
|---|
| Gene, Accession, CAS # | CAS: 1420477-60-6 |
|---|
| Catalog # | MBS846335 |
|---|
| Price | |
|---|
| Order / More Info | Acalabrutinib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|